Intracellular concentrations of posaconazole in different compartments of peripheral blood

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2928-2931

  Farowski, Fedja ^a   Cornely, Oliver A ^a,b   Vehreschild, Jörg J ^a   Hartmann, Pia ^a   Bauer, Tim ^a   Steinbach, Angela ^a   Rüping, Maria J G T ^a   Müller, Carsten ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POSACONAZOLE; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BLOOD SAMPLING; CELL LEVEL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; ERYTHROCYTE; FEMALE; HUMAN; MALE; MYCOSIS; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; AGED; BLOOD; CLINICAL TRIAL; DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; AGED; ANTIFUNGAL AGENTS; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTROPHILS; TRIAZOLES;

EID: 77953748329     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01407-09     Document Type: Article

References (16)

1. Ballesta, S., I. Garcia, E. J. Perea, and A. Pascual. 2005. Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes. J. Antimicrob. Chemother. 55:785-787.
2. Bopp, L. H., A. L. Baltch, W. J. Ritz, P. B. Michelsen, and R. P. Smith. 2006. Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages. J. Med. Microbiol. 55:865-870.
3. Conte, J. E., Jr., J. A. Golden, J. Kipps, M. McIver, and E. Zurlinden. 2004. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state. Antimicrob. Agents Chemother. 48:3823-3827.
4. Conte, J. E., Jr., J. A. Golden, G. Krishna, M. McIver, E. Little, and E. Zurlinden. 2009. Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects. Antimicrob. Agents Chemother. 53:703-707.
5. Cornely, O. A., J. J. Vehreschild, F. Farowski, and M. J. G. T. Rüping. 2008, posting date. Improving diagnosis of severe infections in immunocompromised patients (ISI). http://www.klinisches-studienzentrum.de/med1/ en/trial/552.
6. Farowski, F., O. A. Cornely, J. J. Vehreschild, P. Hartmann, T. Bauer, A. Steinbach, M. J. G. T. Rüping, and C. Müller. 2010. Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography-tandem mass spectrometry. Antimicrob. Agents Chemother. 54:1815-1819.
7. Farowski, F., J. J. Vehreschild, and O. A. Cornely. 2007. Posaconazole: a next-generation triazole antifungal. Future Microbiol. 2:231-243.
8. Harlan, J. M. 1985. Leukocyte-endothelial interactions. Blood 65:513-525.
9. Hope, W. W., E. M. Billaud, J. Lestner, and D. W. Denning. 2008. Therapeutic drug monitoring for triazoles. Curr. Opin. Infect. Dis. 21:580-586.
10. Pascual, A., I. Garcia, C. Conejo, and E. J. Perea. 1993. Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 37:187-190.
11. Perfect, J. R., D. V. Savani, and D. T. Durack. 1993. Uptake of itraconazole by alveolar macrophages. Antimicrob. Agents Chemother. 37:903-904.
12. Schering-Plough. 27 January 2009, posting date. Noxafil product information. http://www.emea.europa.eu/humandocs/Humans/EPAR/posaconazoleSP/ posaconazoleSP.htm.
13. Smith, J., and D. Andes. 2008. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther. Drug Monit. 30:167-172.
14. Smith, W. J., R. H. Drew, and J. R. Perfect. 2009. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update. Expert Rev. Anti Infect. Ther. 7:165-181.
15. Thompson, G. R., III, M. G. Rinaldi, G. Pennick, S. A. Dorsey, T. F. Patterson, and J. S. Lewis II. 2009. Posaconazole therapeutic drug monitoring: a reference laboratory experience. Antimicrob. Agents Chemother. 53:2223-2224.
16. Ullmann, A. J., O. A. Cornely, A. Burchardt, R. Hachem, D. P. Kontoyiannis, K. Topelt, R. Courtney, D. Wexler, G. Krishna, M. Martinho, G. Corcoran, and I. Raad. 2006. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob. Agents Chemother. 50:658-666.